NCT06669091View on ClinicalTrials.gov

Food-effect Study of Ecopipam Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 22, 2024

Study Completion Date

December 27, 2024

Conditions
Food-effect
Interventions
DRUG

Ecopipam tablet

A single ecopipam 89.6 mg tablet (equivalent to ecopipam HCl 100 mg)

Trial Locations (1)

78209

ICON Early Phase Services, San Antonio

Sponsors
All Listed Sponsors
lead

Emalex Biosciences Inc.

INDUSTRY